All Resources

Health indicator : hypertension : age-sex specific incidence rate

Description

This dataset presents information on age-sex specific incidence rates of hypertension for Alberta, expressed as per 100,000 population.

Tags

Health indicator : hypertension : age-standardized incidence rate

Description

This dataset presents information on age-standardized incidence rates of hypertension for Alberta and selected geographies , expressed as per 100,000 population.

Tags

Health indicator : hypertension : age-sex specific prevalence

Description

This dataset presents information on age-sex specific prevalence of hypertension for Alberta, Alberta Health Services (AHS) continuum zone, and former health region, expressed as a percentage.

Tags

Health indicator : hypertension : age-standardized prevalence

Description

This dataset presents information on age-standardized prevalence of hypertension for Alberta and select geographies , expressed as a percentage.

Tags

Incidence of stroke among Albertans with hypertension

Description

This edition of Health Trends Alberta compares the incidence of stroke among Albertans with hypertension to those without.

Tags

Diabetes prevalence among Alberta Hutterites

Description

Looks at the prevalence of diabetes in 2012 among Hutterites and compares them to the non-Hutterite Alberta population.

Tags

Renal denervation for treatment-resistant hypertension

Description

Hypertension (high blood pressure) is a leading cause of stroke, cardiovascular and kidney disease. In most individuals with hypertension blood pressure can be managed through lifestyle changes... More ≫

Description

Hypertension (high blood pressure) is a leading cause of stroke, cardiovascular and kidney disease. In most individuals with hypertension blood pressure can be managed through lifestyle changes and with drug therapies. However, a sub-group of those with hypertension have treatment-resistant hypertension. Renal denervation offers a treatment option for patients in this sub-group. At least three Canadian provinces, including Alberta, have pilot studies of renal denervation planned or underway at the time of publication. This assessment reviews the evidence on renal denervation for the treatment of resistant hypertension in order to support the development of policy recommendations around its provision as a publicly funded service in Alberta.

Tags